---
title: "Creative Castings Ltd (539527) — Share Price, Financials & Analysis"
symbol: "539527"
company: "Creative Castings Ltd"
canonical: "https://tapetide.com/stocks/539527"
isin: "INE146E01015"
nse_symbol: "CREATIVECASTINGSLTD"
bse_code: "539527"
sector: "Industrial Products"
industry: "Castings & Forgings"
market_cap_cr: 85.92
generated_at: "2026-09-13T18:27:46.340Z"
---

# Creative Castings Ltd (539527)

Canonical page: https://tapetide.com/stocks/539527

## Company

- **NSE Symbol:** CREATIVECASTINGSLTD
- **BSE Code:** 539527
- **ISIN:** INE146E01015
- **Sector:** Industrial Products
- **Industry:** Castings & Forgings
- **Macro Sector:** Industrials
- **Stock Type:** EQUITY
- **Listed Since:** 2016-01-04
- **CEO:** Mr. Ketan Chhaganlal Patel
- **Employees:** 370
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** creative-cast.com

## About

Incorporated in 1980, Creative Castings Ltd deals in steel and alloy steel investment castings, and also generates power from 
wind energy.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:41:13.791541Z.

- **Market Cap:** ₹85.92 Cr
- **Classification:** Microcap
- **P/E (reported):** 16.4
- **EPS (TTM):** ₹40.08
- **EPS (reported):** ₹38.16
- **Book Value:** ₹350.54
- **Price to Book:** 1.88
- **Dividend Yield:** 1.9%
- **ROE:** 8.65%
- **ROCE:** 12.43%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹48.28 Cr
- **Net Income:** ₹4.49 Cr
- **EBITDA:** ₹5.37 Cr
- **52-Week High:** ₹723.85
- **52-Week Low:** ₹487.1
- **RSI (14):** 61.13

## Tapetide Score

- **Score:** 68 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Rising
- **Percentile:** 98.8 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 86.85 | 9% |
| growth | 86.07 | 9% |
| momentum | 87.8 | 12% |
| ownership | 50 | 24% |
| quality | 70 | 22% |
| valuation | 62.42 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company is expected to give good quarter

### Weaknesses

- The company has delivered a poor sales growth of 9.53% over past five years.
- Company has a low return on equity of 10.7% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 40.99% | — | 201.68% |
| ebitda margin growth | 21.05% | -19.2% | -20.34% | -4.44% |
| net income growth | 60% | 24.72% | -2% | 11% |
| revenue growth | 25% | 8.25% | -2% | 10% |
| roce | — | -24.71% | -31.52% | 14.66% |
| roe | — | -33.46% | 11.8% | -12.36% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 12.82 | 12.46 | 15.29 | 13.84 | 10.58 | 8.46 | 10.63 | 9.05 | 12.66 | 14.71 | 11.21 | 13.97 |
| Expenses | 11.69 | 11.28 | 12.86 | 12.36 | 9.38 | 7.5 | 9.42 | 8.47 | 11.36 | 12.76 | 9.67 | 12.17 |
| Operating Profit | 1.13 | 1.18 | 2.43 | 1.48 | 1.2 | 0.96 | 1.21 | 0.58 | 1.3 | 1.95 | 1.54 | 1.8 |
| OPM % | 8.81 | 9.47 | 15.89 | 10.69 | 11.34 | 11.35 | 11.38 | 6.41 | 10.27 | 13.26 | 13.74 | 12.88 |
| Other Income | 0.44 | 0.55 | 0.01 | 0.29 | 0.3 | 0.24 | 0.28 | 0.41 | 0.41 | 0.36 | 0.39 | 0.53 |
| Interest | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0.01 | 0 |
| Depreciation | 0.15 | 0.15 | 0.18 | 0.15 | 0.15 | 0.16 | 0.15 | 0.15 | 0.16 | 0.16 | 0.17 | 0.17 |
| Profit before tax | 1.42 | 1.57 | 2.25 | 1.61 | 1.34 | 1.03 | 1.33 | 0.84 | 1.55 | 2.15 | 1.75 | 2.16 |
| Tax % | 20.42 | 33.76 | 18.22 | 41.61 | 22.39 | 43.69 | 21.8 | 10.71 | 32.9 | 26.98 | 42.29 | 26.85 |
| Net Profit | 1.13 | 1.03 | 1.84 | 0.95 | 1.04 | 0.59 | 1.05 | 0.74 | 1.04 | 1.57 | 1.02 | 1.58 |
| EPS in Rs | 8.69 | 7.92 | 14.15 | 7.31 | 8 | 4.54 | 8.08 | 5.69 | 8 | 12.08 | 7.85 | 12.15 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 33.37 | 30.3 | 31.31 | 29.86 | 41.7 | 50.73 | 52.26 | 43.51 | 47.08 | 52.55 |
| Expenses | 29.56 | 26.35 | 28.13 | 26.6 | 37.92 | 45.49 | 45.87 | 38.6 | 41.73 | 45.96 |
| Operating Profit | 3.81 | 3.95 | 3.18 | 3.26 | 3.78 | 5.24 | 6.39 | 4.91 | 5.35 | 6.59 |
| OPM % | 11.42 | 13.04 | 10.16 | 10.92 | 9.06 | 10.33 | 12.23 | 11.28 | 11.36 | 12.54 |
| Other Income | 0.89 | 1.06 | 1.34 | 1.3 | 1.03 | 2 | 0.89 | 1.12 | 1.58 | 1.69 |
| Interest | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.11 | 0.11 | 0.01 | 0.01 |
| Depreciation | 0.61 | 0.6 | 0.59 | 0.66 | 0.59 | 0.75 | 0.63 | 0.6 | 0.64 | 0.66 |
| Profit before tax | 4.08 | 4.4 | 3.92 | 3.89 | 4.22 | 6.48 | 6.54 | 5.32 | 6.28 | 7.61 |
| Tax % | 24.51 | 21.14 | 23.21 | 26.99 | 22.27 | 25.93 | 22.32 | 31.77 | 30.41 | — |
| Net Profit | 3.08 | 3.47 | 3.01 | 2.83 | 3.28 | 4.79 | 5.07 | 3.63 | 4.37 | 5.21 |
| EPS in Rs | 23.69 | 26.69 | 23.15 | 21.77 | 25.23 | 36.85 | 39 | 27.92 | 33.62 | 40.08 |
| Dividend Payout % | 42.21 | 37.46 | 43.19 | 45.94 | 39.63 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
| Reserves | 18.84 | 22.03 | 23.99 | 25.33 | 27.41 | 29.77 | 33.51 | 37.69 | 40.67 | 44.27 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0.12 | 0.08 | 0.12 | 0.14 |
| Other Liabilities | 3.85 | 5.37 | 5.76 | 6.02 | 4.56 | 5.44 | 7.21 | 6.35 | 5.64 | 8.93 |
| Total Liabilities | 23.99 | 28.7 | 31.05 | 32.65 | 33.27 | 36.51 | 42.14 | 45.42 | 47.73 | 54.64 |
| Fixed Assets | 7.57 | 7.64 | 7.22 | 6.72 | 6.38 | 6.34 | 6.18 | 9.39 | 8.72 | 9.27 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0.25 | 0.02 | 1 | 1.07 |
| Investments | 5.28 | 5.48 | 9.26 | 9.43 | 11.4 | 8.25 | 7.53 | 7.78 | 12.26 | 18.16 |
| Other Assets | 11.14 | 15.58 | 14.57 | 16.5 | 15.49 | 21.92 | 28.18 | 28.23 | 25.75 | 26.14 |
| Total Assets | 23.99 | 28.7 | 31.05 | 32.65 | 33.27 | 36.51 | 42.14 | 45.42 | 47.73 | 54.64 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 4.23 | 0.97 | 4.74 | 2.48 | 1.79 | 0.36 | -0.48 | 3.83 | 5.4 | 8.64 |
| Cash from Investing Activity | -1.81 | -0.75 | -3.46 | 0.03 | -1.27 | 3.05 | 0.34 | -3.13 | -4.44 | -6.17 |
| Cash from Financing Activity | -2.21 | -0.01 | -1.58 | -1.57 | -1.31 | -1.3 | -1.18 | -1.36 | -1.29 | -1.3 |
| Net Cash Flow | 0.21 | 0.21 | -0.3 | 0.94 | -0.79 | 2.11 | -1.33 | -0.67 | -0.33 | 1.18 |
| Free Cash Flow | 3.23 | 0.29 | 4.58 | 2.39 | 1.47 | -0.19 | -1.31 | 3.85 | 5.49 | 7.37 |
| CFO/OP | 156 | 51 | 143 | 110 | 81 | 37 | 14 | 87 | 146 | 188 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 75.35 | 94.83 | 91.67 | 73.91 | 79.94 | 71.42 | 105.69 | 92.96 | 74.16 | 69.08 |
| Inventory Days | 118.01 | 88.1 | 110.3 | 167.43 | 169.81 | 151 | 118.79 | 175.1 | 300.24 | 233.09 |
| Days Payable | 103.26 | 104.79 | 103.55 | 98.78 | 47.15 | 42 | 53.56 | 49.35 | 46.15 | 52.63 |
| Cash Conversion Cycle | 90.11 | 78.14 | 98.42 | 142.56 | 202.6 | 180.42 | 170.92 | 218.71 | 328.24 | 249.54 |
| Working Capital Days | 103.2 | 108.4 | 95.04 | 95.71 | 116.37 | 110.81 | 127.93 | 146.32 | 166.35 | 267.24 |
| ROCE % | 16.84 | 19.23 | 18.06 | 15.14 | 13.19 | 12.91 | 18.85 | 17.73 | 13.31 | 14.33 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 23.43% | 23.47% | 23.44% | 22.86% | 22.96% | 22.95% | 22.78% | 22.77% | 22.86% | 22.81% | 23.18% | 23% |
| Others | 1.61% | 1.57% | 1.6% | 2.18% | 2.08% | 2.09% | 2.26% | 2.28% | 2.19% | 2.24% | 1.86% | 2.04% |
| No. of Shareholders | 1621 | 1772 | 1822 | 1900 | 2176 | 2158 | 2114 | 2076 | 2086 | 2024 | 1953 | 1936 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 6 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 659.39 | Sell |
| EMA (10) | 655.13 | Buy |
| SMA (20) | 645.67 | Buy |
| EMA (20) | 643.64 | Buy |
| SMA (50) | 601.4 | Buy |
| EMA (50) | 613.82 | Buy |
| SMA (100) | 582.11 | Buy |
| EMA (100) | 593.15 | Buy |
| SMA (200) | 571.85 | Buy |
| EMA (200) | 586.04 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 60.67 | Neutral |
| MACD (12,26,9) | 16.9 | Sell |
| Stochastic (14,3,3) | 57.25 | Neutral |
| ADX (14) | 40.18 | Buy |
| Williams %R (14) | -45.98 | Neutral |
| ATR (14) | 21.62 | High Volatility |
| ROC (12) | 3.77 | Buy |
| Stoch RSI (14) | 20.46 | Neutral |
| UO (7,14,28) | 57.54 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=909ac6c5-3f41-453f-8603-07b51be6e728.pdf) |
| 2026-09-01 | [Notice Of 41St Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e54b506-2cba-4a2a-827c-3284caf0254d.pdf) |
| 2026-09-01 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2921ac79-261b-48ab-8ca2-c4e97f2dcbeb.pdf) |
| 2026-08-02 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e37747f-0b8d-4727-a41c-a4436b9cba6c.pdf) |
| 2026-08-01 | [Board Meeting Outcome for Unaudited Financial Results Dividend Record Date AGM RPT Etc.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cadfd40-6d99-4399-a823-eeed21130e4a.pdf) |
| 2026-08-01 | [Corporate Action-Board to consider Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edfa02ae-6597-4dec-ad73-5c8664afe627.pdf) |
| 2026-08-01 | [Corporate Action - Fixes Record Date For 41St AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=907d7585-a390-4c41-9105-37d4ee44c71a.pdf) |
| 2026-08-01 | [Annual General Meeting (AGM) For The FY 2025-26 Scheduled On Saturday September 26 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ff61400-2502-4886-9bca-4f83058f0f45.pdf) |
| 2026-08-01 | [Announcement under Regulation 30 (LODR)-Dividend Updates](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64cb3757-d318-4968-8b7c-32ddc3f344bd.pdf) |
| 2026-07-23 | [Board Meeting Intimation for Board Meeting Intimation For Adoption Of Unaudited Financial Results Of Q1 Final Dividend Recommendation Fixing Of Date Of AGM And Record Date Adoption Of Annual Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4512709d-3dc9-42e9-b216-45c14ee1d31c.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-01 | [Results- Unaudited Financial Results For June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8b1dede-7870-400e-8886-a63ffbc74dde.pdf) |
| 2026-05-16 | [Results-Financial Results For The Quarter And Year Ended On March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7b24e5a-5586-4642-b533-10b4fc4d0ee1.pdf) |
| 2026-01-31 | [Unaudited Financial Results For December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11add180-fb1e-4d7c-9053-fc26e578d321.pdf) |
| 2025-11-08 | [Unaudited Financial Results For September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99439ff3-2937-493f-afce-a1889de8fa79.pdf) |
| 2025-07-26 | [Results- Unaudited Financial Results For June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9a1d7a0-6218-46c7-8124-684d5aac5fe1.pdf) |
| 2025-05-24 | [Results-Financial Results For The Quarter And Year Ended On March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fe8f8a7-13d8-48d7-8a07-4f0e80393126.pdf) |
| 2025-01-28 | [Results - Unaudited Financial Results For December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ee1adfb-5d63-46ad-bf84-08889071378a.pdf) |
| 2024-10-26 | [Results- Unaudited Financial Results For September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd871143-732c-4456-a1c9-fa8fb76a76e0.pdf) |
| 2024-08-10 | [Results- Unaudited Financial Results For June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51459796-8e1b-42d3-947b-a822485a542e.pdf) |
| 2024-05-25 | [Results-Financial Results For The Quarter And Year Ended On March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=383b2744-f432-47c3-99f2-a64999785593.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7h - Novartis received Draft Letter of Offer dated March 05, 2026 for open offer by ChrysCapital, WaveRise, Two Infinity. | [Intimation Of Receipt Of Draft Letter Of Offer Received From Manager To Open Offer (Axis Capital Limited). 7h - Novartis received Draft Letter of Offer dated March 05, 2026 for open offer by ChrysCapital, WaveRise, Two Infinity.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0b32c70a-23b1-4e39-aec5-a39336a141f5.pdf) |
| 7 May - Board meeting on 16 May 2026 to approve audited FY26 results. | [Board Meeting Intimation for Audited Financial Results For The Quarter And Financial Year Ended On March 31, 2026 7 May - Board meeting on 16 May 2026 to approve audited FY26 results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f364c2dc-cee4-4ec7-98c1-80a8fa46fe2a.pdf) |
| 5h - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026 is enclosed hereto. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5h - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026 is enclosed hereto.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/93e493fe-3118-44c1-9d69-2aceed7d39b6.pdf) |
| 31 Jan - Q3/9M FY26 unaudited results: Qtr revenue Rs1,507.49L; 9M revenue Rs3,803.29L; Qtr PAT Rs157.22L; limited review. | [Unaudited Financial Results For December 31, 2025 31 Jan - Q3/9M FY26 unaudited results: Qtr revenue Rs1,507.49L; 9M revenue Rs3,803.29L; Qtr PAT Rs157.22L; limited review.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/11add180-fb1e-4d7c-9053-fc26e578d321.pdf) |
| 29 Jan - Of newspaper advertisement by Novartis India Limited (''the Company'') regarding the publication of Unaudited Financial Results of the Company for the quarter ended December 31, … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Jan - Of newspaper advertisement by Novartis India Limited (''the Company'') regarding the publication of Unaudited Financial Results of the Company for the quarter ended December 31, …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/194e027b-6ff7-4c99-ba1f-937fbef94ded.pdf) |
| 29 Jan - Novartis India clarifies incorrect Q3 figures for quarter ended Dec 31, 2025; article withdrawn and corrected sources provided. | [Rumour verification - Regulation 30(11) 29 Jan - Novartis India clarifies incorrect Q3 figures for quarter ended Dec 31, 2025; article withdrawn and corrected sources provided.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/15f37fd6-c1a5-439e-b91a-b9386518386f.pdf) |
| 28 Jan - Submitted unaudited financials and limited review for quarter ended Dec 31, 2025; no debt/defaults reported. | [Integrated Filing (Financial) For The Quarter Ended December 31, 2025. 28 Jan - Submitted unaudited financials and limited review for quarter ended Dec 31, 2025; no debt/defaults reported.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bcbcb00e-9aa6-4e62-a609-aa0914ade777.pdf) |
| 28 Jan - Board approved unaudited results for quarter ended Dec 31, 2025; limited review report dated Jan 28, 2026. | [Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Novartis India Limited ('The Company') Held On Wednesday, January 28, 2026. 28 Jan - Board approved unaudited results for quarter ended Dec 31, 2025; limited review report dated Jan 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/817ac14d-cea5-410b-ab70-c3c4a11cbc0b.pdf) |
| 26 Feb - Open offer at INR 860.64 for 26% (64.19 lakh) shares; SPA sells 70.68% to Acquirers. | [Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer 26 Feb - Open offer at INR 860.64 for 26% (64.19 lakh) shares; SPA sells 70.68% to Acquirers.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3f34c8fe-9c9f-41bd-82f2-ea43e3113ee9.pdf) |
| 26 Feb - Mandatory open offer for 26% of Novartis India at INR860.64; SPA transfers 70.68% control to Acquirers. | [Detailed Public Statement 26 Feb - Mandatory open offer for 26% of Novartis India at INR860.64; SPA transfers 70.68% control to Acquirers.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/E4F66B93-DA75-4FB6-9BFE-781416D9CE02-181410.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4ca2b229-36f0-4585-9c8e-5e0d077304c4.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9b32edf6-bdd8-41da-99bb-560368b2317a.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9b0205b9-16fe-4d7a-804f-d67959700767.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/48cc6923-7ce9-486c-959a-ffadf35cfeae.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b415137f-f341-406c-ad13-6aa820190ca1.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b13a4b7a-18bb-4bd6-a7d5-ded204610360.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500672/73362500672.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539527/74997539527.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500672/69195500672.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539527/69652539527.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:27:46.340Z.